Blue Biofuels, Inc. Q1 2026 Financial Report: Detailed Analysis for Investors

Key Highlights from the Quarterly Report

• Quarterly Report Filed: Blue Biofuels, Inc. (OTCQB: BIOF) filed its Form 10-Q for the quarter ended March 31, 2026.
• Common Stock: The company’s common stock trades under the symbol “BIOF” on the OTCQB. No securities are registered under Section 12(b) of the Exchange Act.
• Reporting Status and Compliance: The company confirms full compliance with SEC filing requirements and electronic data submissions for the past 12 months.
• Classification: Blue Biofuels is classified as a “smaller reporting company” and is not a shell company or an emerging growth company.
• Shares Outstanding: As of March 31, 2026, there were 320,948,112 shares of common stock outstanding, with a par value of \$0.001 per share.

Financial Performance Overview

Condensed Balance Sheet

• Total Assets: \$1,309,640 as of March 31, 2026 (down from \$1,407,379 at December 31, 2025).
• Total Liabilities and Stockholders’ Deficit: \$1,309,640 as of March 31, 2026.
• Stockholders’ Deficit: The company reports a negative stockholders’ equity (deficit) of \$(3,936,726) at March 31, 2026, compared to \$(3,706,083) at year-end 2025. This increasing deficit is a key risk factor and may be material for investors.
• Interest Payable – Related Party: \$152,484 as of March 31, 2026.
• No Preferred Stock Issued: The company had zero shares of preferred stock issued and outstanding.

Operations and Net Income

• Net Loss for the Quarter: Blue Biofuels reported a net loss of \$(663,801) for the quarter ended March 31, 2026, compared to a net loss of \$(444,970) for the same period in 2025. This increased loss is significant and could impact investor sentiment.
• Earnings Per Share: Basic and diluted net loss per share was \$(0.002) for Q1 2026, compared to \$(0.001) for Q1 2025.
• Weighted Average Shares Outstanding: 319,225,834 (Q1 2026) vs. 308,459,719 (Q1 2025).
• Interest Expense – Related Party: The company incurred interest expenses with a related party during the period.

Equity and Capital Raising Activities

• Stock Issued for Services: During Q1 2026, the company issued common stock valued at \$10 and recognized \$1,240 in additional paid-in capital for services rendered.
• Warrants Issued for Interest: 30,000 warrants were issued for interest, recognized as \$4,303 in additional paid-in capital.
• Private Placement: The company raised \$227,000 in cash through private placement, issuing 1,816,000 shares of common stock and warrants. The capital raised included \$1,816 in par value and \$225,184 in additional paid-in capital.

Stockholders’ Equity Movement

• Ending Balances as of March 31, 2026:
  • Common Stock: \$320,948
  • Additional Paid-in Capital: \$56,536,489
  • Accumulated Deficit: \$(60,794,163)
  • Total Stockholders’ Equity (Deficit): \$(3,936,726)

Investor Considerations and Price-Sensitive Information

• Continued Losses and Growing Deficit: The increased net loss and growing stockholders’ deficit remain key risks. Investors should be aware that the company continues to operate at a loss and relies on external capital to fund operations.
• Ongoing Dilution: New shares and warrants were issued for both services and cash. This continued dilution may impact existing shareholders’ percentage ownership and could weigh on the share price if investors view the dilution as excessive or if future capital raises are required.
• Financing Activities: The successful private placement raises near-term liquidity, but the company’s ongoing cash burn and deficit suggest that further financing may be needed in the future.
• No Preferred Stock or Change in Classification: The absence of preferred stock issuance and the company’s status as a smaller reporting company mean no change in capital structure or reporting obligations.

Conclusion

Blue Biofuels’ Q1 2026 report reveals a company still in the development or growth phase, with ongoing operating losses and reliance on capital raises to fund its operations. The increase in net losses and negative equity may be a concern for some investors, but the successful private placement demonstrates continued access to funding. Shareholders and potential investors should closely monitor the company’s ability to manage cash, reduce losses, and execute on its business strategy, as these factors will likely influence future share price performance.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should perform their own due diligence and consult with a licensed financial advisor before making any investment decisions. The information is based on the company’s unaudited financial statements and may not reflect subsequent events or updated filings.

View BLUE BIOFUELS, INC. Historical chart here